Transabdominal ultrasound with echoenhancement by contrast media in the diagnosis of hepatocellular carcinoma

Digestive Diseases

Volumn 27, Issue 2, 2009, Pages 109-113

  Schacherer, Doris ^a   Girlich, Christiane ^a   Jung, Michael E ^a   Wiest, Reiner ^a   Schölmerich, Juergen ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

B mode sonography; Contrast enhanced sonography; Doppler sonography; Echoenhancement; Transabdominal ultrasound

Indexed keywords

GADOLINIUM CHELATE; IODINATED CONTRAST MEDIUM; SONOVUE; SULFUR HEXAFLUORIDE;

B SCAN; CANCER DIAGNOSIS; CANCER RISK; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOGRAPHY; EUROPE; HUMAN; LIVER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER NECROSIS; MICROBUBBLE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; TUMOR VASCULARIZATION; ULTRASOUND;

CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; HUMANS; LIVER NEOPLASMS; MICROBUBBLES; ULTRASONOGRAPHY, DOPPLER;

EID: 67650932117     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218342     Document Type: Review

References (32)

1. Bosch FX, Ribes J, Diaz M, Cleries R: Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004;127:516.
2. Tangkijvanich P, Mahachai V, Suwangool P,Poovorawan Y: Gender difference in clinico pathologic features and survival of patients with hepatocellular carcinoma. World J Gastroenterol 2004;10:15471550.
3. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christen sen E, Pagliaro L, Colombo M, Rodes J;EASL Panel of Experts on HCC: Clinical management of hepatocellular carcinoma.Conclusions of the Barcelona 2000 EASLConference. European Association for the Study of the Liver. J Hepatol 2001;35:421430.
4. Bruix J, Sherman M: Management of hepa tocellular carcinoma. Hepatology 2005; 42:12081236.
5. Mazzaferro V, Battiston C, Perrone S, Pulvi renti A, Regalia E, Romito R, et al: Radiofre quency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg 2004;240:900909.
6. Peterson MS, Baron RL: Radiologic diagnosis of hepatocellular carcinoma. Clin Liver Dis 2001;5:123144.
7. Marrero JA: Screening tests for hepatocellu lar carcinoma. Clin Liver Dis 2005; 9: 235-251.
8. Liu WC, Lim JH, Park CK, Kim MJ, Kim SH, Lee SJ, Lee WJ, Lim HK: Poor sensitivity of sonography in detection of hepatocellular carcinoma in advanced liver cirrhosis: accuracy of pretransplantation sonography in 118 patients. Eur Radiol 2003;13:16931698
9. Caturelli E, Pompili M, Bartolucci F, Siena DA, Sperandeo M, Andriulli A, et al: Hem angiomelike lesions in chronic liver disease: diagnostic evaluation in patients. Radiology 2001;220:337342.
10. Lencioni R, Pinto F, Armillotta N, Bartolozzi C: Assessment of tumor vascularity in hepatocellular carcinoma: comparison of power Doppler US and color Doppler US. Radiology 1996;201:353358.
11. Tanaka S, Ioka T, Oshikawa O, Hamada Y,Yoshioka F: Dynamic sonography of hepatic tumors. AJR Am J Roentgenol 2001; 177:799-805.
12. Isozaki T, Numata K, Kiba T, Hara K, Mori moto M, Sakaguchi T, Sekihara H, Kubota T, Shimada H, Morizane T, Tanaka K: Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US.Radiology 2003; 229: 798805.
13. Albrecht T, Blomley M, Bolondi L, ClaudonM, Correas JM, Cosgrove D, Greiner L, Jager K, Jong ND, Leen E, Lencioni R, Lindsell D, Martegani A, Solbiati L, Thorelius L, Tran quart F, Weskott HP, Whittingham T; EF SUMB Study Group: Guidelines for the use of contrast agents in ultrasound, January 2004. Ultraschall Med 2004; 25: 249256.
14. Leen E, Angerson WJ, Yarmenitis S, Bon gartz G, Blomley M, Del Maschio A, Sum maria V, Maresca G, Pezzoli C, Llull JB: Multicentre clinical study evaluating the efficacy of SonoVue (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions. Eur J Radiol 2002; 41:200206.
15. Quaida E, Calliada F, Bertolotto M, Rossi S, Garioni L, Rosa L, PozziMucelli R: Characterization of focal liver lesions with contrast specific US modes and a sulfur hexafluoride filled microbubble contrast agent: diagnostic performance and confidence. Radiology2004;232: 420430.
16. D'Onofrio M, Faccioli N, Zamboni G,Malago R, Caffarri S, Fattovich G, Mucelli RP: Focal liver lesions in cirrhosis: value of contrastenhanced ultrasonography compared with Doppler ultrasound and afeto protein levels. Radiol Med 2008; 113:978991.
17. Strobel D, Seitz K, Blank W, Schuler A, Dietrich C, von Herbay A, FriedrichRust M,Kunze G, Becker D, Will U, Kratzer W, Albert FW, Pachmann C, Dirks K, Strunk H,Greis C, Bernatik T: Contrastenhanced ultrasound for the characterization of focal liver lesions diagnostic accuracy in clinicalpractice (DEGUM multicenter trial). Ultraschall Med 2008; 29: 499505.
18. Gaiani S, Celli N, Piscaglia F, Cecilioni L,Losinno F, Giangregorio F, Mancini M, Pini P, Fornari F, Bolondi L: Usefulness of contrastenhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. J Hepatol 2004;41:421426.
19. Solbiati L, Tonolini M, Cova L, Goldberg SN:The role of contrastenhanced ultrasound in the detection of focal liver lesions. Eur Ra diol 2001;11(suppl 3):E15E26.
20. Numata K, Tanaka K, Kiba T, Saito S, Ikeda M, Hara K, Tanaka N, Morimoto M, Iwase S, Sekihara H: Contrastenhanced, wideband harmonic gray scale imaging of hepatocel lular carcinoma: correlation with helical computed tomographic findings. J Ultrasound Med 2001; 20:8998.
21. Rickes S, Ocran K, Schulze S, Wermke W: valuation of Doppler sonographic criteria or the differentiation of hepatocellular carcinomas and regenerative nodules in patients with liver cirrhosis. Ultraschall Med2002;23:8390.
22. Forner A, Vilana R, Ayuso C, Bianchi L, Sole, Ayuso JR et al: Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic riteria for hepatocellular carcinoma. Hepatology 2008; 47: 97104.
23. Xu HX, Xie XY, Lu MD, Liu GJ, Xu ZF, ZhengYL, Liang JY, Chen LD: Contrastenhancedsonography in the diagnosis of small hepatocellular carcinoma < or = 2 cm. J Clin Ultrasound 2008; 36:257266.
24. Pompili M, Riccardi L, Semeraro S, OreficeR, Elia F, Barbaro B, Covino M, Grieco A,Gasbarrini G, Rapaccini GL: Contrastenhanced ultrasound assessment of arterialvascularization of small nodules arising in he cirrhotic liver. Dig Liver Dis 2008; 40:206215.
25. Liu GJ, Xu HX, Lu MD, Xie XY, Xu ZF, Zheng L, Liang JY: Correlation between enhancement pattern of hepatocellular carcinoma on ealtime contrastenhanced ultrasound and umor cellular differentiation on histopa thology. Br J Radiol 2007; 80:321330.
26. Gaiani S, Bolondi L, Li Bassi S, Zirondi G,Siringo S, Barbara L: Prevalence of spontaneous hepatofugal portal flow pattern in liver cirrhosis. Clinical and endoscopic evaluation in 228 patients. Gastroenterology 1991;100:160167.
27. Tarantino L, Francica G, Sordelli L, Esposito F, Giorgio A, Sorrentino P, et al: Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrasten hanced US, and fineneedle biopsy. Abdom Imaging 2006;31: 537544.
28. Piscaglia F, Gianstefani A, Ravaioli M, Sagri ni E, Lodato F, Morelli C, et al: Reliability of imaging techniques in assessing portal venous thrombosis in patients with hepatocel lular carcinoma candidates for liver transplantation. Ultraschall Med 2007; 28:S35.
29. Pompili M, Mirante VG, Rondinara G, Fas sati LR, Piscaglia F, Agnes S, Covino M, Ra vaioli M, Fagiuoli S, Gasbarrini G, Rapaccini GL: Percutaneous ablation procedures in cir rhotic patients with hepatocellular carcinoma submitted to liver transplantation: assessment of efficacy at explant analysis and of safety for tumor recurrence. Liver Transplant 2005;9:11171126.
30. Farina R, Pennisi F, Mazzone G, Pennisi M,Riva G, Foti PV, Puglisi C, Ettorre GC: Power Doppler ultrasonography with timesignal intensity curves in monitoring hepato cellular carcinoma and liver metastases after intralesional therapy. Radiol Med 2009; 114:3241.
31. Nicolau C, Vilana R, Bianchi L, Bru C: Early stage hepatocellular carcinoma: the high accuracy of realtime contrastenhanced ultrasonography in the assessment of response to percutaneous treatment. Eur Radiol 2007;17(suppl 6):F80F88.
32. Lencioni R, Piscaglia F, Bolondi L: Contrast enhanced ultrasound in the diagnosis of he patocellular carcinoma. J Hepatol 2008; 48:848857.